Halozyme Therapeutics Net Total Equity Issued/Repurchased 2010-2025 | HALO
Halozyme Therapeutics net total equity issued/repurchased for the twelve months ending March 31, 2025 was $-0.182B, a 73.49% decline year-over-year.
- Halozyme Therapeutics annual net total equity issued/repurchased for 2024 was $-0.219B, a 44.52% decline from 2023.
- Halozyme Therapeutics annual net total equity issued/repurchased for 2023 was $-0.395B, a 112.15% increase from 2022.
- Halozyme Therapeutics annual net total equity issued/repurchased for 2022 was $-0.186B, a 44.91% decline from 2021.